CRYOMASS TECHNOLOGIES INC - CRYM STOCK NEWS

CryoMass Technologies announced the sale of its first CryoSift Separator™ production model for CAD$1.62 million, to be deployed in Canada. The sale is part of a multi-party Equipment Lease and Non-Exclusive Patent License agreement, which will also generate recurring revenue from processing fees. The new modular system dramatically reduces biomass volume by 65% and enhances both performance and versatility. The buyer has 60 days to complete the payment. This marks a significant milestone in CryoMass's growth strategy and aims to introduce its cryogenic technology to Canada's mature cannabis market.

CryoMass Technologies Inc. has reached an agreement with CRYM Co-Invest GP to sell up to five CryoSift Separator™ Units for a total of up to US$6 million. The innovative financing structure provides growth capital to CryoMass while enabling wider deployment of the Company's processing technology. The funding arrangement will be non-dilutive to CryoMass shareholders, while providing a recurring revenue stream from processing fees charged to Clients. Access to capital has been an ongoing challenge for prospective Clients working in the cannabis industry due to federal prohibition.

CryoMass signs license agreement with RubberRock Inc. for large-scale cannabinoid production, guaranteeing at least $3 million in annual royalties. CryoMass aims to scale its disruptive technology and increase revenue potential.

CryoMass Technologies Inc. announces successful transition to commercial processing phase with its Trichome Separation Beta unit. The company has achieved a major milestone by designing and constructing an industrial-scale Beta system. CryoMass expects to receive scheduled payments from RedTape over the next 12 months and is engaged in discussions for market expansion.

CryoMass Technologies Inc. (OTCQX: CRYM) announced the signing of a multi-state license agreement with RedTape Core Partners LLC on January 18, 2023. This follows the delivery of CryoMass' Trichome Separation unit to RedTape's facility in Monterrey, California, for beta testing.

The licensed agreement includes a total investment of US$10.2 million over 2023 for the deployment of 12 Trichome Separation systems. The partnership aims to enhance hemp and cannabis processing capabilities across California, New York, New Jersey, Florida, and Pennsylvania.

CryoMass Technologies (OTC: CRYM) announced the Canadian Intellectual Property Office granted it a patent (#3064896) for a novel cryogenic separation process for plant material, valid until 2039. This patent follows similar protections granted in the U.S. and China, effective until 2038. CEO Christian Noël emphasized the significance of this patent in the booming $50 billion cannabis/hemp industry and its potential applications across agriculture. The company aims to enhance its global patent portfolio, including upcoming applications in the European Union.

CryoMass Technologies has initiated real-time trials for its patented cryogenic system designed for extracting high-value elements from hemp and cannabis plants. The system, measuring 160 square feet and operating with ultra-cold liquid nitrogen, aims to enhance efficiency and quality in cannabinoid capture. Preliminary results show throughput rates of 400-600 kg/hour and a capture rate of 96-97%. The company believes the device offers significant advantages over conventional methods, which typically incur a loss of around one-third of cannabinoids.

CryoMass Technologies Inc. has initiated real-time trials of its patented cryogenic system for hemp and cannabis extraction. The equipment, which measures 160 square feet and operates at ultra-cold temperatures, aims to maximize cannabinoid capture and efficiency. Preliminary results show a throughput of 400-600 kg/hour and a cannabinoid capture rate between 96% and 97%. The system promises significant time and cost savings over traditional methods, potentially benefiting large-scale cultivators and processors of botanicals.

CryoMass Technologies Inc. announced the election of Simon Langelier to its board of directors. With over 30 years of experience at Philip Morris International, Langelier has held senior positions in various regions, including President of Eastern Europe, Middle East & Africa. He currently serves as a director at Imperial Brands PLC and is an Honorary Professorial Fellow at Lancaster University. The chairman of CryoMass expressed confidence in Langelier's ability to contribute valuable insights to the company.